Trials that use: P-values
New to this method? Read the tutorial →
20,601 results
- Placebo-controlled Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy: Complete Statistical AnalysisIndependent statistical analysis of Placebo-controlled Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Placebo-Controlled, Single-Dose Challenge Study of Gaboxadol in Adult Males With Fragile X Syndrome (FXS): Complete Statistical AnalysisIndependent statistical analysis of Placebo-Controlled, Single-Dose Challenge Study of Gaboxadol in Adult Males With Fragile X Syndrome (FXS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Placebo-Corrected Effects of Therapeutic Dose (100 mg) and Supratherapeutic Dose (300 mg) of ITF2357 (Givinostat) and Moxifloxacin on QT/QTC Interval: Complete Statistical AnalysisIndependent statistical analysis of Placebo-Corrected Effects of Therapeutic Dose (100 mg) and Supratherapeutic Dose (300 mg) of ITF2357 (Givinostat) and Moxifloxacin on QT/QTC Interval: primary endpoint results, effect estimate with confidence interval,…
- PLADOIndependent statistical analysis of Optimal Platelet Dose Strategy for Management of Thrombocytopenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00128713).
- Plan and Pledge, HIV Self-testing in South Africa: Complete Statistical AnalysisIndependent statistical analysis of Plan and Pledge, HIV Self-testing in South Africa: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03898557).
- PLANE-PCIndependent statistical analysis of Pembrolizumab and Lenvatinib in Advanced/Metastatic Neuroendocrine Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04848337).
- PLANETIndependent statistical analysis of Aflibercept in Polypoidal Choroidal Vasculopathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02120950).
- PLANET 1Independent statistical analysis of Prospective Evaluation of Proteinuria and Renal Function in Diabetic Patients With Progressive Renal Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Planned Donor Lymphocyte Infusion (DLI) After Allogeneic Stem Cell Transplantation (SCT): Complete Statistical AnalysisIndependent statistical analysis of Planned Donor Lymphocyte Infusion (DLI) After Allogeneic Stem Cell Transplantation (SCT): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Plantar Heel Pain: Multisegment Foot Motion and Muscle Function, FFI Translation, and Evaluation of Treatments: Complete Statistical AnalysisIndependent statistical analysis of Plantar Heel Pain: Multisegment Foot Motion and Muscle Function, FFI Translation, and Evaluation of Treatments: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Plasma of Argon Cleaning on Implant Abutments: 5-year Results of a Randomized Clinical Trial: Complete Statistical AnalysisIndependent statistical analysis of Plasma of Argon Cleaning on Implant Abutments: 5-year Results of a Randomized Clinical Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Plasma Therapy of COVID-19 in Severely Ill Patients: Complete Statistical AnalysisIndependent statistical analysis of Plasma Therapy of COVID-19 in Severely Ill Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04359810).
- Plasmodium Vivax Efficacy Trial in Cruzeiro do Sul, Acre, Brazil: Complete Statistical AnalysisIndependent statistical analysis of Plasmodium Vivax Efficacy Trial in Cruzeiro do Sul, Acre, Brazil: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02043652).
- Platelet -Rich Plasma (PRP) Injection for the Treatment of Severe Dry Eye: Complete Statistical AnalysisIndependent statistical analysis of Platelet -Rich Plasma (PRP) Injection for the Treatment of Severe Dry Eye: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Platelet Rich Plasma in Levator Ani Muscle Trauma: Complete Statistical AnalysisIndependent statistical analysis of Platelet Rich Plasma in Levator Ani Muscle Trauma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03021954).
- Platelet Rich Plasma Injection in Pilon Fractures: Complete Statistical AnalysisIndependent statistical analysis of Platelet Rich Plasma Injection in Pilon Fractures: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02481869).
- Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC) – Sub-study 3: Complete Statistical AnalysisIndependent statistical analysis of Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC) - Sub-study 3: primary endpoint results, effect estimate with confidence…
- PLATINUMIndependent statistical analysis of The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions: primary endpoint results, effect estimate with confidence interval, sample-size…
- Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy: Complete Statistical AnalysisIndependent statistical analysis of Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- PLATINUM QCAIndependent statistical analysis of A Prospective, Multi-center Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Platinum-Based Chemotherapy Plus Ramucirumab in Patients With Advanced NSCLC Who Have Progressed on First Line Anti-PD-1 Immunotherapy: Complete Statistical AnalysisIndependent statistical analysis of Platinum-Based Chemotherapy Plus Ramucirumab in Patients With Advanced NSCLC Who Have Progressed on First Line Anti-PD-1 Immunotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- PLATOIndependent statistical analysis of A Comparison of Ticagrelor (AZD6140) and Clopidogrel in Patients With Acute Coronary Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- PLAYIndependent statistical analysis of Multicenter Study for Pediatric Subjects Evaluating Pharmacokinetics and Safety of EXPAREL: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Play Intervention for Dementia for Promoting Cognitive Function: A Feasibility Study: Complete Statistical AnalysisIndependent statistical analysis of Play Intervention for Dementia for Promoting Cognitive Function: A Feasibility Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Plerixafor and Cemiplimab in Metastatic Pancreatic Cancer: Complete Statistical AnalysisIndependent statistical analysis of Plerixafor and Cemiplimab in Metastatic Pancreatic Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04177810).
- Plerixafor and Filgrastim For Mobilization of Donor Peripheral Blood Stem Cells Before A Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies: Complete Statistical AnalysisIndependent statistical analysis of Plerixafor and Filgrastim For Mobilization of Donor Peripheral Blood Stem Cells Before A Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies: primary endpoint results,…
- Plerixafor and Sargramostim (GM-CSF) for Mobilization of Allogeneic Sibling Donors: Complete Statistical AnalysisIndependent statistical analysis of Plerixafor and Sargramostim (GM-CSF) for Mobilization of Allogeneic Sibling Donors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01158118).
- Plerixafor Versus G-CSF in the Treatment of People With WHIM Syndrome: Complete Statistical AnalysisIndependent statistical analysis of Plerixafor Versus G-CSF in the Treatment of People With WHIM Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- PleuraSeal Post Market Study (Europe): Complete Statistical AnalysisIndependent statistical analysis of PleuraSeal Post Market Study (Europe): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00704171).
- Pleurectomy/Decortication With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Sodium Thiosulfate: Complete Statistical AnalysisIndependent statistical analysis of Pleurectomy/Decortication With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Sodium Thiosulfate: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00165503).
- PLHIVIndependent statistical analysis of Traditional Healers as Adherence Partners for Persons Living With HIV in Rural Mozambique: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- PLIANTIndependent statistical analysis of A Trial of PledOx + FOLFOX6 Compared to Placebo + FOLFOX6 in Patients With Metastatic Colorectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 2: Complete Statistical AnalysisIndependent statistical analysis of Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 2: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Ploidy and Stroma in Early Rectal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Ploidy and Stroma in Early Rectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03039595).
- PLUMIndependent statistical analysis of Post-Prandial Liver Glucose Metabolism in PCOS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03041129).
- PLUSIndependent statistical analysis of Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Leg After a Stroke: primary endpoint results, effect estimate with confidence interval,…
- PLUSIndependent statistical analysis of Improving HIV and Alcohol-Related Outcomes Among HIV+ Persons in Clinic Settings: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- PLX038 (PEGylated SN38) and Rucaparib in Solid Tumors and Small Cell Cancers: Complete Statistical AnalysisIndependent statistical analysis of PLX038 (PEGylated SN38) and Rucaparib in Solid Tumors and Small Cell Cancers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- PLX2853 as a Single Agent in Advanced Gynecological Malignancies and in Combination With Carboplatin in Platinum-Resistant Epithelial Ovarian Cancer: Complete Statistical AnalysisIndependent statistical analysis of PLX2853 as a Single Agent in Advanced Gynecological Malignancies and in Combination With Carboplatin in Platinum-Resistant Epithelial Ovarian Cancer: primary endpoint results, effect estimate with confidence interval, sample-size…
- PLX2853 in Combination With Abiraterone Acetate and Prednisone and in Combination With Olaparib in Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC): Complete Statistical AnalysisIndependent statistical analysis of PLX2853 in Combination With Abiraterone Acetate and Prednisone and in Combination With Olaparib in Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC): primary endpoint results, effect estimate with confidence…
- PMCF Study on PEEK Suture Anchors for Shoulder Indications: Complete Statistical AnalysisIndependent statistical analysis of PMCF Study on PEEK Suture Anchors for Shoulder Indications: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03826667).
- PMCF Study on the Safety and Performance of the Alloclassic Variall Cup Ceramic Bearing System in Total Hip Arthroplasty: Complete Statistical AnalysisIndependent statistical analysis of PMCF Study on the Safety and Performance of the Alloclassic Variall Cup Ceramic Bearing System in Total Hip Arthroplasty: primary endpoint results, effect estimate with confidence interval, sample-size…
- PMNCIndependent statistical analysis of Evaluation of the Spectra Optia PMN Cell Collection Procedure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01805180).
- PMOD03Independent statistical analysis of Dysport in Post-Surgical Neuralgia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03663101).
- PMP-300EIndependent statistical analysis of PMP-300E (Smart Watch): Portable Monitoring Device Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01364740).
- PMS of Trazenta on the Long-term Use as Add-on Therapy: Complete Statistical AnalysisIndependent statistical analysis of PMS of Trazenta on the Long-term Use as Add-on Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01904383).
- PMS-001Independent statistical analysis of An Open-Label Study of Oral NNZ-2591 in Phelan-McDermid Syndrome (PMS-001): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05025241).
- pNAATIndependent statistical analysis of Performance of Nucleic Acid Amplification Tests for the Detection of NG and CT: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- PNCAIndependent statistical analysis of Parent/Nurse Controlled Analgesia in the Neonatal Intensive Care Unit: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01823497).
- PNEU-AGEIndependent statistical analysis of Safety and Immunogenicity of V114 in Healthy Adults (V114-019/PNEU-AGE): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03950622).